Clinical Trials Logo

Clinical Trial Summary

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that results in progressive paralysis of the muscles involved in voluntary motor skills, speech, swallowing and breathing. It also causes non-motor symptoms including psychological, cognitive and behavioral difficulties that have a negative impact on patients' quality of life, well-being and long-term development. There is no curative therapy for ALS and drug treatments have little effect on non-motor symptoms. Interventions based on mindfulness meditation, defined as a state of consciousness that arises when one decides to focus attention in the present moment without judgment on the real experience, seem to be a promising tool for the reduction of non-motor symptoms in a number of progressive neurological conditions (Alzheimer's disease, multiple sclerosis, etc.), suggesting that mindfulness significantly helps in the management of these symptoms. Our project therefore aims to implement a mindfulness meditation program adapted to the management of non-motor symptoms in ALS based on virtual reality (VR).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05409508
Study type Interventional
Source University Hospital, Angers
Contact
Status Not yet recruiting
Phase N/A
Start date September 2022
Completion date June 2023

See also
  Status Clinical Trial Phase
Completed NCT04972773 - Spinal Cord Injury Mental Health Functional Outcomes Improved by Mindfulness N/A
Completed NCT04786405 - Mindfulness Meditation Versus Clinical Hypnosis for Acute, Experimental Pain Phase 2